# Nutritional status and metabolic alterations in patients with ataxia-telangiectasia

## TL;DR

This study examines how patients with ataxia-telangiectasia experience malnutrition and metabolic changes, including worsening liver function and lipid levels over time.

## Contribution

The study provides a large-scale analysis of nutritional and metabolic profiles in ataxia-telangiectasia patients across Latin America.

## Key findings

- A significant increase in severe thinness among patients over time was observed.
- High levels of glucose, triglycerides, cholesterol, and abnormal LDL-c were common in patients.
- Progressive liver function deterioration was indicated by rising aspartate aminotransferase levels.

## Abstract

Ataxia-telangiectasia (A-T) is a DNA repair disorder characterized by progressive degeneration, immunodeficiency, cancer predisposition, malnutrition, metabolic disorders, and chronic liver disease. The study aims to describe the nutritional status and plasma levels of biomarkers of lipid status, metabolic profile, and liver function of patients with A-T.

A total of 218 patients from 9 Latin American countries were included in the study. The distribution of patients according to nutritional status by age group revealed an over-time increase in the proportion of patients with severe thinness (p = 0.016). High glucose and triglyceride levels were observed in 9.5% and 23.6% of patients, respectively. Total cholesterol was high in 31.7, and 34.0% had abnormal LDL-c levels. In the analysis of paired samples, a progressive increase in aspartate aminotransferase was observed over time.

The present results are comparable to those of previous studies also showing changes in nutritional status and in lipid, metabolic, and liver profiles over time. These findings confirm a high rate of thinness in patients with A-T and progressive deterioration as the disease progresses, as well as changes in plasma levels of biomarkers of lipid status, metabolic profile, and liver function.